Skip to content
TrialMatch
Sign up
Recruiting

Semi-closed Loop Automated Insulin Therapy in the Pediatric Population Aged 2-6 Years With Type 1 Diabetes: Impact on Quality of Life and Glycemic Control

Create a profile to match View the full record on ClinicalTrials.gov

About this study

The incidence of type 1 diabetes is increasing, with an incidence of +4% per year in France today. The treatment for type 1 diabetes is insulin therapy. In recent years, new systems have emerged, so-called "semi-closed loop" systems, also called automated insulin therapy, which have proven their superiority in terms of quality of life and glycemic balance in adults and children over 6 years old. Since January 24, 2024, the HAS now recognizes the indication of the semi-closed loop for the YPSOPUMP model in children aged 2 to 6 years. This is the first reimbursement in France of a closed loop system for the 2-6 year old age group. There are currently few studies comparing the quality of life of children in semi-closed loop versus other treatments (open loop or injections). Regarding quality of life, the studies found mainly concern the contribution for parents and the improvement of adolescents' sleep as in the study by Erin C Cobry et al from 2020 (6). Our study therefore aims to demonstrate an improvement in quality of life but also in diabetes balance in type 1 diabetic patients on a closed loop insulin pump versus open loop or injections in the pediatric population aged 2-6 years.

Condition
Type 1 Diabetes, Closed Loop, Insulin, Quality of Life, Pediatric
Sponsor
Fondation Lenval

Who can join

Age
2 to 6 years
Sex
All sexes
Healthy volunteers
Not accepted

Inclusion 9

  • Minimum age: 2 years
  • Maximum age: 6 years
  • Study condition: Type 1 Diabetes, Closed Loop, Insulin, Quality of Life, Pediatric
  • -Patients aged 2 to 6 years inclusive
  • Presenting type 1 diabetes on insulin therapy
  • Social security affiliates
  • Patient initiating semi-closed loop treatment
  • Family (at least one parent or representative of parental authority) agreeing to follow the training necessary for continuous measurement of glucose in real time.
  • collection of non-opposition from one of the two parents or the representative of parental authority agreement

Exclusion 1

  • Opposition to participation in research involving humans or opposition to the use of data or samples and associated data (withdrawal of non-opposition).

Where

1 site, 1 recruiting

Fondation Lenval Hôpitaux pédiatrique Nice CHU Lenval

Nice, France, France

Recruiting

Contact

Potential match only. Final eligibility is determined by the study team.